• U.S. Burden of Skin and Subcutaneous Diseases Increasing

    Healthday News Conditions, HealthDay News Physician's Briefing June 25, 2020
  • Can dermatology employers require employees to receive the COVID-19 vaccine?

    American Academy of Dermatology AAD, Conditions, Coronavirus, COVID-19 January 28, 2021
  • THE 2020 VISION FOR NEMOLIZUMAB IN ATOPIC DERMATITIS

    American Academy of Dermatology AAD, Atopic Dermatitis, Conditions, Dermatology January 26, 2021
  • Expression of retinoid receptors in hand eczema.

    ClinOwl Atopic Dermatitis, ClinOwl, Conditions, Eczema October 1, 2020
  • S. aureus Agr Virulence Tied to Atopic Dermatitis in Infants

    Healthday News Atopic Dermatitis, Conditions, Eczema July 28, 2020
  • Psoriasis, biological drugs and Coronavirus Disease 2019: Real life experience of two Italian provinces.

    ClinOwl ClinOwl, Conditions, COVID-19, Psoriasis July 26, 2020

DermConnect® is an official licensee of the American Academy of Dermatology.

DermConnect®
Navigation
  • Home
  • Atopic Dermatitis
  • Psoriasis
    • Chronic Plaque Psoriasis
    • Guttate Psoriasis
  • Skin Cancer
    • Basal Cell Carcinoma
    • Cutaneous T-cell Lymphoma
    • Dermatofibrosarcoma Protuberans (DFSP)
    • Melanoma
    • Merkel Cell Carcinoma
    • Sebaceous Carcinoma
    • Squamous Cell Carcinoma
  • Home
  • Atopic Dermatitis
  • Psoriasis
    • Chronic Plaque Psoriasis
    • Guttate Psoriasis
  • Skin Cancer
    • Basal Cell Carcinoma
    • Cutaneous T-cell Lymphoma
    • Dermatofibrosarcoma Protuberans (DFSP)
    • Melanoma
    • Merkel Cell Carcinoma
    • Sebaceous Carcinoma
    • Squamous Cell Carcinoma
Home Posts Dermatology

Category Archive

  • Dermatology / April 18, 2021

    Do we need skin toxicity? Association of immune checkpoint inhibitor and tyrosine kinase inhibitor-related cutaneous adverse events with outcomes in metastatic renal cell carcinoma.

    View Post
  • Dermatology / November 3, 2020

    Trichoscopic signs of tinea capitis: a guide for selection of appropriate antifungal.

    View Post
  • Dermatology / March 8, 2021

    Evaluation of biophysical skin parameters and hair changes in patients with acne vulgaris treated with isotretinoin, and the effect of biotin use on these parameters.

    View Post
  • Dermatology / October 10, 2020

    Ulcerative versus non-ulcerative panniculitis: is it time for a novel clinical approach to panniculitis?

    View Post
  • Dermatology / January 30, 2021

    Next Generation Sequencing analysis suggests varied multistep mutational pathogenesis for Endocrine Mucin Producing Sweat Gland Carcinoma with comments on INSM1 and MUC2 suggesting a conjunctival origin.

    View Post

Atopic eczema and obesity: a population-based study.

In Dermatology
by ClinOwl
October 21, 2020

Atopic eczema is a common chronic inflammatory skin disease. Research suggests an association between atopic eczema and obesity, with inconsistent evidence from European populations.To explore the association between diagnosed atopic …

Association between atopic dermatitis and autoimmune diseases: a population-based case-control study.

In Dermatology
by ClinOwl
October 21, 2020

Atopic dermatitis (AD) is a common chronic skin disorder and well-known to be associated with other atopic conditions. There is increasing evidence for an association also with non-atopic conditions, including …

Balanopreputial sac and urine microbiota in patients with male genital lichen sclerosus.

In Dermatology
by ClinOwl
October 20, 2020

Male genital lichen sclerosus (MGLSc) is a chronic inflammatory scarring dermatosis associated with penile carcinoma. The prepuce is pivotal in its etiology. Other proposed etiological factors are the subject of …

The climate emergency: why should dermatologists care, and how can they act?

In Dermatology
by ClinOwl
October 16, 2020

Weather and climate exist on a massive scale: over the last 650,000 years, only seven glacial cycles have occurred. The end of the last ice age 12,000 years ago marked …

International validation of the Bullous Pemphigoid Disease Area Index (BPDAI) severity score and calculation of cut-off values for defining mild, moderate and severe type of bullous pemphigoid.

In Dermatology
by ClinOwl
October 16, 2020

The Bullous-Pemphigoid-Disease-Area-Index (BPDAI) score has been proposed to provide an objective measure of bullous pemphigoid (BP) activity.To calculate BPDAI cut-off values defining mild, moderate and severe BP, and to assess …

Aetiology and pathogenesis of hidradenitis suppurativa.

In Dermatology
by ClinOwl
October 12, 2020

Hidradenitis suppurativa (HS) is a chronic inflammatory disorder. Patients develop inflamed nodules and abscesses and, at later stages of disease, epithelialized tunnels and scars in skinfolds of axillary, inguinal, gluteal …

The novel application of syringes in dermabrasion surgery.

In Dermatology
by ClinOwl
October 12, 2020

In this article, we try to use the syringes without the piston part to control the amount of saline fluid in dermabrasion surgery. It is very convenient to obtain materials …

Multidrug-resistant Trichophyton mentagrophytes genotype VIII in an Iranian family with generalized dermatophytosis: report of four cases and review of literature.

In Dermatology
by ClinOwl
October 12, 2020

The global spread of terbinafine-resistant Trichophyton mentagrophytes with point mutations in the squalene epoxidase (SQLE) gene is a big concern.The present study presents a series of unusual familial cases of …

Thrombotic complications with interruption of direct oral anticoagulants in dermatologic surgery.

In Dermatology
by ClinOwl
October 11, 2020

Direct oral anticoagulants (DOACs) i.e. apixaban, rivaroxaban, and dabigatran are increasingly being utilized to provide prophylaxis and treatment for arterial and venous thromboembolism. While multiple procedural subspecialties have implemented guidelines …

Contact Dermatitis to Personal Care Products is Increasing (but Different!) in Males and Females: North American Contact Dermatitis Group (NACDG) Data, 1996-2016.

In Dermatology
by ClinOwl
October 10, 2020

Personal care products(PCPs) are commonly responsible for allergic(ACD) and irritant contact dermatitis(ICD). PCP use was historically associated with women but increasingly, male-targeted PCPs are being marketed.To characterize and compare males …

  • Page 50 of 57
  • ←
  • 1
  • ...
  • 49
  • 50
  • 51
  • ...
  • 57
  • →

TRENDING

  • Dose Range for Iberdomide Studied in Systemic Lupus Erythematosus
  • YouTube Video Quality for Aesthetic Injectables Lower Than Quality of Websites
  • Cardiac Biomarkers and CV Risk Examined in Psoriatic Disease
  • Lymph Node Dissection Declining in SLN-Positive Melanoma
  • Debt Valuation of Private Equity-Backed Dermatology Groups Down

About DermConnect®

DermConnect® curates the latest in dermatology news and resources from some of the most trusted and respected names in healthcare, including the American Academy of Dermatology, ClinOwl, HealthDay and Dermnet NZ.

LATEST ARTICLES

  • Dose Range for Iberdomide Studied in Systemic Lupus Erythematosus March 16, 2022
  • YouTube Video Quality for Aesthetic Injectables Lower Than Quality of Websites March 11, 2022
  • Cardiac Biomarkers and CV Risk Examined in Psoriatic Disease March 11, 2022
  • Lymph Node Dissection Declining in SLN-Positive Melanoma March 9, 2022
  • Debt Valuation of Private Equity-Backed Dermatology Groups Down March 9, 2022

Quick Links

  • Home
  • Atopic Dermatitis
  • Psoriasis
    • Chronic Plaque Psoriasis
    • Guttate Psoriasis
  • Skin Cancer
    • Basal Cell Carcinoma
    • Cutaneous T-cell Lymphoma
    • Dermatofibrosarcoma Protuberans (DFSP)
    • Melanoma
    • Merkel Cell Carcinoma
    • Sebaceous Carcinoma
    • Squamous Cell Carcinoma

About DermConnect®

DermConnect® curates the latest in dermatology news and resources from some of the most trusted and respected names in healthcare, including the American Academy of Dermatology, ClinOwl, HealthDay and Dermnet NZ.

SCHEDULE

June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
« Mar    

All content indicated on this website as authored by "AAD" is owned by and licensed with the permission of the American Academy of Dermatology (“AAD”) for personal educational use.

The content may not be distributed in whole or in part to any third parties without express written permission from AAD,
nor may viewers of this site translate, edit, modify or otherwise create derivative works from the content.

The licensing of the content by AAD does not constitute or imply any endorsement of any company and/or any of its goods, services or written work product.

 

  • Home
  • Atopic Dermatitis
  • Psoriasis
  • Skin Cancer